Bone or cartilage mass screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Bone or cartilage mass}} {{CMG}} {{AE}}{{MV}} ==Overview== ==Screening== ==References== {{Reflist|1}}") |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
According to the the National Cancer Institute (NCI) there is insufficient evidence to recommend routine screening for bone or cartilage tumors.<ref name="US">Bone Cancer—Health Professional Version (2016) http://www.cancer.gov/types/bone/hp Accessed on February, 8th 2016</ref> | |||
==Screening== | ==Screening== | ||
According to the the National Cancer Institute (NCI) there is insufficient evidence to recommend routine screening for bone or cartilage tumors.<ref name="US">Bone Cancer—Health Professional Version (2016) http://www.cancer.gov/types/bone/hp Accessed on February, 8th 2016</ref> | |||
==References== | ==References== | ||
{{Reflist|1}} | {{Reflist|1}} |
Revision as of 20:00, 8 February 2016
Bone or Cartilage Mass Microchapters |
Diagnosis |
---|
Case Studies |
Bone or cartilage mass screening On the Web |
American Roentgen Ray Society Images of Bone or cartilage mass screening |
Risk calculators and risk factors for Bone or cartilage mass screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
According to the the National Cancer Institute (NCI) there is insufficient evidence to recommend routine screening for bone or cartilage tumors.[1]
Screening
According to the the National Cancer Institute (NCI) there is insufficient evidence to recommend routine screening for bone or cartilage tumors.[1]
References
- ↑ 1.0 1.1 Bone Cancer—Health Professional Version (2016) http://www.cancer.gov/types/bone/hp Accessed on February, 8th 2016